Cowen Assumes Exagen (XGN) at Outperform
Tweet
Share
E-mailGet Alerts XGN Hot Sheet
Price: $6.66 +1.22%
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
9 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cowen analyst Max Masucci assumes coverage on Exagen (NASDAQ: XGN) with a Outperform rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Exagen click here. For more ratings news on Exagen click here.
Shares of Exagen closed at $12.71 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
